Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDK2 Antikörper

CDK2 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 1A6 unconjugated
Produktnummer ABIN969506
  • Target Alle CDK2 Antikörper anzeigen
    CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
    Reaktivität
    • 186
    • 105
    • 86
    • 11
    • 10
    • 8
    • 8
    • 8
    • 7
    • 6
    • 6
    • 6
    • 4
    • 3
    • 3
    • 3
    • 2
    Human, Maus
    Wirt
    • 188
    • 20
    • 1
    Maus
    Klonalität
    • 179
    • 30
    Monoklonal
    Konjugat
    • 99
    • 17
    • 15
    • 10
    • 7
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser CDK2 Antikörper ist unkonjugiert
    Applikation
    • 170
    • 75
    • 52
    • 49
    • 48
    • 39
    • 27
    • 22
    • 21
    • 11
    • 10
    • 8
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of human CDK2 expressed in E. coli.
    Klon
    1A6
    Isotyp
    IgG1
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, ICC: 1:200 - 1:1000, FCM: 1:200 - 1:400
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified antibody in PBS with 0.05 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Markowski, Tyszkiewicz, Jarzab, Oczko-Wojciechowska, Gierek, Witkowska, Paluch, Kowalska, Wygoda, Lange, Jarzab: "Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma." in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, Vol. 266, Issue 10, pp. 1501-7, (2009) (PubMed).

  • Target
    CDK2 (Cyclin-Dependent Kinase 2 (CDK2))
    Andere Bezeichnung
    CDK2 (CDK2 Produkte)
    Synonyme
    p33(CDK2) antikoerper, A630093N05Rik antikoerper, wu:fa10c02 antikoerper, zgc:56598 antikoerper, zgc:77684 antikoerper, eg1 antikoerper, CDKN2 antikoerper, cdk2L antikoerper, cyclin dependent kinase 2 antikoerper, cyclin-dependent kinase 2 antikoerper, cyclin-dependent kinase 2 S homeolog antikoerper, CDK2 antikoerper, Cdk2 antikoerper, cdk2 antikoerper, cdk2.S antikoerper
    Hintergrund

    Description: The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein kinase is highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2. It is a catalytic subunit of the cyclin-dependent protein kinase complex, whose activity is restricted to the G1-S phase, and essential for cell cycle G1/S phase transition. This protein associates with and regulated by the regulatory subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A) and p27Kip1 (CDKN1B). Its activity is also regulated by its protein phosphorylation. Two alternatively spliced variants and multiple transcription initiation sites of this gene have been reported.

    Aliases: p33

    Molekulargewicht
    33.9 kDa
    Gen-ID
    1017
    HGNC
    1017
    Pathways
    PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
Sie sind hier:
Kundenservice